ANIXA BIOSCIENCES, INC. Costs and Expenses
ANIXA BIOSCIENCES, INC. (ANIX) reported Costs and Expenses of $2.74 million for the 3-month period ending 2026-07-31, per its 10-Q filed 2026-09-09.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:CostsAndExpenses · last filed 2026-09-09
- ANIXA BIOSCIENCES, INC. costs and expenses for the quarter ending 2026-07-31 was $2.74M, a 12.36% increase year-over-year.
- ANIXA BIOSCIENCES, INC. costs and expenses for the quarter ending 2026-04-30 was $2.65M, a 11.85% decline year-over-year.
- ANIXA BIOSCIENCES, INC. costs and expenses for the quarter ending 2026-01-31 was $2.72M, a 19.79% decline year-over-year.
- ANIXA BIOSCIENCES, INC. costs and expenses for the quarter ending 2025-10-31 was $2.88M, a 9.07% decline year-over-year.
- ANIXA BIOSCIENCES, INC. costs and expenses for fiscal 2025 was $11.70M, a 15.40% decline from fiscal 2024.
- ANIXA BIOSCIENCES, INC. costs and expenses for fiscal 2024 was $13.83M, a 23.26% increase from fiscal 2023.
- ANIXA BIOSCIENCES, INC. costs and expenses for fiscal 2023 was $11.22M, a 19.13% decline from fiscal 2022.
- ANIXA BIOSCIENCES, INC. costs and expenses for fiscal 2022 was $13.88M, a 1.66% increase from fiscal 2021.
| Period end | Costs and Expenses 3 month | Costs and Expenses 3 month as first filed | Costs and Expenses 6 month | Costs and Expenses 6 month as first filed | Costs and Expenses 9 month | Costs and Expenses 9 month as first filed | Costs and Expenses 12 month | Costs and Expenses 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-07-31 | $2.74M 10-Q · filed 2026-09-09 | $5.38M derived: sum of 2 quarters · filed 2026-09-09 | $8.10M 10-Q · filed 2026-09-09 | $10.98M derived: sum of 4 quarters · filed 2026-09-09 | ||||
| 2026-04-30 | $2.65M 10-Q · filed 2026-06-10 | $5.36M 10-Q · filed 2026-06-10 | $8.24M derived: sum of 3 quarters · filed 2026-06-10 | $10.68M derived: sum of 4 quarters · filed 2026-09-09 | ||||
| 2026-01-31 | $2.72M 10-Q · filed 2026-03-09 | $5.59M derived: sum of 2 quarters · filed 2026-03-09 | $8.03M derived: sum of 3 quarters · filed 2026-09-09 | $11.03M derived: sum of 4 quarters · filed 2026-09-09 | ||||
| 2025-10-31 | $2.88M derived: 10-K 12 month − 10-Q 9 month · filed 2026-01-12 | $5.31M derived: sum of 2 quarters · filed 2026-09-09 | $8.31M derived: sum of 3 quarters · filed 2026-09-09 | $11.70M 10-K · filed 2026-01-12 | ||||
| 2025-07-31 | $2.44M 10-Q · filed 2026-09-09 | $5.44M derived: sum of 2 quarters · filed 2026-09-09 | $8.82M 10-Q · filed 2026-09-09 | $11.99M derived: sum of 4 quarters · filed 2026-09-09 | ||||
| 2025-04-30 | $3.00M 10-Q · filed 2026-06-10 | $6.39M 10-Q · filed 2026-06-10 | $9.55M derived: sum of 3 quarters · filed 2026-06-10 | $13.14M derived: sum of 4 quarters · filed 2026-06-10 | ||||
| 2025-01-31 | $3.39M 10-Q · filed 2026-03-09 | $6.55M derived: sum of 2 quarters · filed 2026-03-09 | $10.14M derived: sum of 3 quarters · filed 2026-03-09 | $13.61M derived: sum of 4 quarters · filed 2026-03-09 | ||||
| 2024-10-31 | $3.16M derived: 10-K 12 month − 10-Q 9 month · filed 2026-01-12 | $6.75M derived: sum of 2 quarters · filed 2026-01-12 | $10.22M derived: sum of 3 quarters · filed 2026-01-12 | $13.83M 10-K · filed 2026-01-12 | ||||
| 2024-07-31 | $3.59M 10-Q · filed 2025-09-10 | $7.06M derived: sum of 2 quarters · filed 2025-09-10 | $10.67M 10-Q · filed 2025-09-10 | $13.72M derived: sum of 4 quarters · filed 2025-09-10 | ||||
| 2024-04-30 | $3.47M 10-Q · filed 2025-05-28 | $7.08M 10-Q · filed 2025-05-28 | $10.13M derived: sum of 3 quarters · filed 2025-05-28 | $12.97M derived: sum of 4 quarters · filed 2025-05-28 | ||||
| 2024-01-31 | $3.61M 10-Q · filed 2025-03-11 | $6.66M derived: sum of 2 quarters · filed 2025-03-11 | $9.50M derived: sum of 3 quarters · filed 2025-03-11 | $12.27M derived: sum of 4 quarters · filed 2025-03-11 | ||||
| 2023-10-31 | $3.05M derived: 10-K 12 month − 10-Q 9 month · filed 2025-01-10 | $5.89M derived: sum of 2 quarters · filed 2025-01-10 | $8.66M derived: sum of 3 quarters · filed 2025-01-10 | $11.22M 10-K · filed 2025-01-10 | ||||
| 2023-07-31 | $2.84M 10-Q · filed 2024-09-06 | $5.61M derived: sum of 2 quarters · filed 2024-09-06 | $8.17M 10-Q · filed 2024-09-06 | $11.78M derived: sum of 4 quarters · filed 2024-09-06 | ||||
| 2023-04-30 | $2.77M 10-Q · filed 2024-06-04 | $5.33M 10-Q · filed 2024-06-04 | $8.94M derived: sum of 3 quarters · filed 2024-06-04 | $11.73M derived: sum of 4 quarters · filed 2024-06-04 | ||||
| 2023-01-31 | $2.56M 10-Q · filed 2024-03-12 | $6.17M derived: sum of 2 quarters · filed 2024-03-12 | $8.96M derived: sum of 3 quarters · filed 2024-03-12 | $12.55M derived: sum of 4 quarters · filed 2024-03-12 | ||||
| 2022-10-31 | $3.61M derived: 10-K 12 month − 10-Q 9 month · filed 2024-01-16 | $6.41M derived: sum of 2 quarters · filed 2024-01-16 | $9.99M derived: sum of 3 quarters · filed 2024-01-16 | $13.88M 10-K · filed 2024-01-16 | ||||
| 2022-07-31 | $2.80M 10-Q · filed 2023-09-06 | $6.39M derived: sum of 2 quarters · filed 2023-09-06 | $10.27M 10-Q · filed 2023-09-06 | $14.34M derived: sum of 4 quarters · filed 2023-09-06 | ||||
| 2022-04-30 | $3.59M 10-Q · filed 2023-06-14 | $7.47M 10-Q · filed 2023-06-14 | $11.54M derived: sum of 3 quarters · filed 2023-06-14 | $15.93M derived: sum of 4 quarters · filed 2023-06-14 | ||||
| 2022-01-31 | $3.88M 10-Q · filed 2023-03-17 | $7.96M derived: sum of 2 quarters · filed 2023-03-17 | $12.34M derived: sum of 3 quarters · filed 2023-03-17 | $14.78M derived: sum of 4 quarters · filed 2023-03-17 | ||||
| 2021-10-31 | $4.08M derived: 10-K 12 month − 10-Q 9 month · filed 2023-01-04 | $8.46M derived: sum of 2 quarters · filed 2023-01-04 | $10.90M derived: sum of 3 quarters · filed 2023-01-04 | $13.65M 10-K · filed 2023-01-04 | $13.65M 10-K · filed 2022-01-04 | |||
| 2021-07-31 | $4.39M 10-Q · filed 2022-09-09 | $4.39M 10-Q · filed 2021-09-01 | $6.83M derived: sum of 2 quarters · filed 2022-09-09 | $9.57M 10-Q · filed 2022-09-09 | $9.57M 10-Q · filed 2021-09-01 | $11.81M derived: sum of 4 quarters · filed 2022-09-09 | ||
| 2021-04-30 | $2.44M 10-Q · filed 2022-06-10 | $2.44M 10-Q · filed 2021-06-10 | $5.18M 10-Q · filed 2022-06-10 | $5.18M 10-Q · filed 2021-06-10 | $7.43M derived: sum of 3 quarters · filed 2022-06-10 | $9.86M derived: sum of 4 quarters · filed 2022-06-10 | ||
| 2021-01-31 | $2.75M 10-Q · filed 2022-03-11 | $2.75M 10-Q · filed 2021-03-11 | $4.99M derived: sum of 2 quarters · filed 2022-03-11 | $7.42M derived: sum of 3 quarters · filed 2022-03-11 | $10.09M derived: sum of 4 quarters · filed 2022-03-11 | |||
| 2020-10-31 | $2.24M derived: 10-K 12 month − 10-Q 9 month · filed 2022-01-04 | $4.68M derived: sum of 2 quarters · filed 2022-01-04 | $7.35M derived: sum of 3 quarters · filed 2022-01-04 | $9.98M 10-K · filed 2022-01-04 | ||||
| 2020-07-31 | $2.44M 10-Q · filed 2021-09-01 | $5.11M derived: sum of 2 quarters · filed 2021-09-01 | $7.74M 10-Q · filed 2021-09-01 | $9.86M derived: sum of 4 quarters · filed 2021-09-01 | ||||
| 2020-04-30 | $2.67M 10-Q · filed 2021-06-10 | $5.30M 10-Q · filed 2021-06-10 | $7.43M derived: sum of 3 quarters · filed 2021-06-10 | $9.61M derived: sum of 4 quarters · filed 2021-06-10 | ||||
| 2020-01-31 | $2.63M 10-Q · filed 2021-03-11 | $4.76M derived: sum of 2 quarters · filed 2021-03-11 | $6.94M derived: sum of 3 quarters · filed 2021-03-11 | $9.79M derived: sum of 4 quarters · filed 2021-03-11 | ||||
| 2019-10-31 | $2.13M derived: 10-K 12 month − 10-Q 9 month · filed 2021-01-07 | $4.31M derived: sum of 2 quarters · filed 2021-01-07 | $7.16M derived: sum of 3 quarters · filed 2021-01-07 | $12.14M 10-K · filed 2021-01-07 | ||||
| 2019-07-31 | $2.18M 10-Q · filed 2020-09-08 | $5.03M derived: sum of 2 quarters · filed 2020-09-08 | $10.01M 10-Q · filed 2020-09-08 | $15.42M derived: sum of 4 quarters · filed 2020-09-08 | ||||
| 2019-04-30 | $2.84M 10-Q · filed 2020-06-09 | $7.83M 10-Q · filed 2020-06-09 | $13.23M derived: sum of 3 quarters · filed 2020-06-09 | $19.20M derived: sum of 4 quarters · filed 2020-06-09 | ||||
| 2019-01-31 | $4.98M 10-Q · filed 2020-03-09 | $10.39M derived: sum of 2 quarters · filed 2020-03-09 | $16.36M derived: sum of 3 quarters · filed 2020-03-09 | $18.51M derived: sum of 4 quarters · filed 2020-03-09 | ||||
| 2018-10-31 | $5.41M derived: 10-K 12 month − 10-Q 9 month · filed 2020-01-09 | $11.38M derived: sum of 2 quarters · filed 2020-01-09 | $13.53M derived: sum of 3 quarters · filed 2020-01-09 | $15.40M 10-K · filed 2020-01-09 | ||||
| 2018-07-31 | $5.97M 10-Q · filed 2019-09-06 | $8.12M derived: sum of 2 quarters · filed 2019-09-06 | $9.99M 10-Q · filed 2019-09-06 | $11.73M derived: sum of 4 quarters · filed 2019-09-06 | ||||
| 2018-04-30 | $2.15M 10-Q · filed 2019-06-12 | $4.03M 10-Q · filed 2019-06-12 | $5.76M derived: sum of 3 quarters · filed 2019-06-12 | $7.86M derived: sum of 4 quarters · filed 2019-06-12 | ||||
| 2018-01-31 | $1.87M 10-Q · filed 2019-03-13 | $3.61M derived: sum of 2 quarters · filed 2019-03-13 | $5.71M derived: sum of 3 quarters · filed 2019-03-13 | $6.92M derived: sum of 4 quarters · filed 2019-03-13 | ||||
| 2017-10-31 | $1.74M derived: 10-K 12 month − 10-Q 9 month · filed 2019-01-11 | $3.83M derived: sum of 2 quarters · filed 2019-01-11 | $5.04M derived: sum of 3 quarters · filed 2019-01-11 | $6.44M 10-K · filed 2019-01-11 | ||||
| 2017-07-31 | $2.09M 10-Q · filed 2018-09-07 | $3.31M derived: sum of 2 quarters · filed 2018-09-07 | $4.70M 10-Q · filed 2018-09-07 | $5.81M derived: sum of 4 quarters · filed 2018-09-07 | ||||
| 2017-04-30 | $1.21M 10-Q · filed 2018-06-11 | $2.61M 10-Q · filed 2018-06-11 | $3.72M derived: sum of 3 quarters · filed 2018-06-11 | $4.80M derived: sum of 4 quarters · filed 2018-06-11 | ||||
| 2017-01-31 | $1.39M 10-Q · filed 2018-03-09 | $2.51M derived: sum of 2 quarters · filed 2018-03-09 | $3.58M derived: sum of 3 quarters · filed 2018-03-09 | $4.73M derived: sum of 4 quarters · filed 2018-03-09 | ||||
| 2016-10-31 | $1.11M derived: 10-K 12 month − 10-Q 9 month · filed 2018-01-09 | $2.19M derived: sum of 2 quarters · filed 2018-01-09 | $3.34M derived: sum of 3 quarters · filed 2018-01-09 | $4.81M 10-K · filed 2018-01-09 | ||||
| 2016-07-31 | $1.07M 10-Q · filed 2017-09-08 | $2.22M derived: sum of 2 quarters · filed 2017-09-08 | $3.70M 10-Q · filed 2017-09-08 | $4.87M derived: sum of 4 quarters · filed 2017-09-08 | ||||
| 2016-04-30 | $1.15M 10-Q · filed 2017-05-26 | $2.62M 10-Q · filed 2017-05-26 | $3.80M derived: sum of 3 quarters · filed 2017-05-26 | $5.38M derived: sum of 4 quarters · filed 2017-05-26 | ||||
| 2016-01-31 | $1.47M 10-Q · filed 2017-03-16 | $2.65M derived: sum of 2 quarters · filed 2017-03-16 | $4.24M derived: sum of 3 quarters · filed 2017-03-16 | $6.39M derived: sum of 4 quarters · filed 2017-03-16 | ||||
| 2015-10-31 | $1.18M derived: 10-K 12 month − 10-Q 9 month · filed 2016-12-08 | $2.76M derived: sum of 2 quarters · filed 2016-12-08 | $4.92M derived: sum of 3 quarters · filed 2016-12-08 | $10.20M 10-K · filed 2016-12-08 | ||||
| 2015-07-31 | $1.59M 10-Q · filed 2016-08-19 | $3.74M derived: sum of 2 quarters · filed 2016-08-19 | $9.02M 10-Q · filed 2016-08-19 | $11.96M derived: sum of 4 quarters · filed 2016-08-19 | ||||
| 2015-04-30 | $2.16M 10-Q · filed 2016-05-20 | $7.44M 10-Q · filed 2016-05-20 | $10.38M derived: sum of 3 quarters · filed 2016-05-20 | $11.72M derived: sum of 4 quarters · filed 2016-05-20 | ||||
| 2015-01-31 | $5.28M 10-Q · filed 2016-02-19 | $8.22M derived: sum of 2 quarters · filed 2016-02-19 | $9.56M derived: sum of 3 quarters · filed 2016-02-19 | $12.02M derived: sum of 4 quarters · filed 2016-02-19 | ||||
| 2014-10-31 | $2.94M derived: 10-K 12 month − 10-Q 9 month · filed 2015-12-23 | $4.29M derived: sum of 2 quarters · filed 2015-12-23 | $6.75M derived: sum of 3 quarters · filed 2015-12-23 | $8.71M 10-K · filed 2015-12-23 | ||||
| 2014-07-31 | $1.35M 10-Q · filed 2015-08-18 | $3.81M derived: sum of 2 quarters · filed 2015-08-18 | $5.77M 10-Q · filed 2015-08-18 | $7.94M derived: sum of 4 quarters · filed 2015-08-18 | ||||
| 2014-04-30 | $2.46M 10-Q · filed 2015-05-22 | $4.43M 10-Q · filed 2015-05-22 | $6.59M derived: sum of 3 quarters · filed 2015-05-22 | $8.81M derived: sum of 4 quarters · filed 2015-05-22 | ||||
| 2014-01-31 | $1.96M 10-Q · filed 2015-03-09 | $4.13M derived: sum of 2 quarters · filed 2015-03-09 | $6.35M derived: sum of 3 quarters · filed 2015-03-09 | $8.20M derived: sum of 4 quarters · filed 2015-03-09 | ||||
| 2013-10-31 | $2.16M derived: 10-K 12 month − 10-Q 9 month · filed 2015-01-29 | $4.38M derived: sum of 2 quarters · filed 2015-01-29 | $6.23M derived: sum of 3 quarters · filed 2015-01-29 | $8.31M 10-K · filed 2015-01-29 | ||||
| 2013-07-31 | $2.22M 10-Q · filed 2014-09-15 | $4.07M derived: sum of 2 quarters · filed 2014-09-15 | $6.14M 10-Q · filed 2014-09-15 | $6.14M 10-Q/A · filed 2013-09-20 | $7.86M derived: sum of 4 quarters · filed 2014-09-15 | |||
| 2013-04-30 | $1.85M 10-Q · filed 2014-06-16 | $3.92M 10-Q · filed 2014-06-16 | $3.93M 10-Q/A · filed 2013-06-19 | $5.64M derived: sum of 3 quarters · filed 2014-06-16 | $6.54M derived: sum of 4 quarters · filed 2014-06-16 | |||
| 2013-01-31 | $2.07M 10-Q · filed 2014-03-17 | $2.07M 10-Q/A · filed 2013-03-25 | $3.79M derived: sum of 2 quarters · filed 2014-03-17 | $4.68M derived: sum of 3 quarters · filed 2014-03-17 | $5.81M derived: sum of 4 quarters · filed 2014-03-17 | |||
| 2012-10-31 | $1.72M derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2014-01-17 | $2.61M derived: sum of 2 quarters · filed 2014-01-17 | $3.74M derived: sum of 3 quarters · filed 2014-01-17 | $5.07M 10-K/A · filed 2014-01-17 | $5.08M 10-K · filed 2013-01-29 | |||
| 2012-07-31 | $892.81K 10-Q/A · filed 2013-09-20 | $2.02M derived: sum of 2 quarters · filed 2013-09-20 | $3.36M 10-Q/A · filed 2013-09-20 | $4.81M derived: sum of 4 quarters · filed 2013-09-20 | ||||
| 2012-04-30 | $1.13M 10-Q/A · filed 2013-06-19 | $2.46M 10-Q/A · filed 2013-06-19 | $3.92M derived: sum of 3 quarters · filed 2013-06-19 | $5.58M derived: sum of 4 quarters · filed 2013-06-19 | ||||
| 2012-01-31 | $1.34M 10-Q/A · filed 2013-03-25 | $2.79M derived: sum of 2 quarters · filed 2013-03-25 | $4.45M derived: sum of 3 quarters · filed 2013-03-25 | $5.82M derived: sum of 4 quarters · filed 2013-03-25 | ||||
| 2011-10-31 | $1.46M derived: 10-K 12 month − 10-Q 9 month · filed 2013-01-29 | $3.11M derived: sum of 2 quarters · filed 2013-01-29 | $4.49M derived: sum of 3 quarters · filed 2013-01-29 | $6.03M 10-K · filed 2013-01-29 | ||||
| 2011-07-31 | $1.66M 10-Q · filed 2012-09-14 | $3.03M derived: sum of 2 quarters · filed 2012-09-14 | $4.58M 10-Q · filed 2012-09-14 | $6.01M derived: sum of 4 quarters · filed 2012-09-14 | ||||
| 2011-04-30 | $1.37M 10-Q · filed 2012-06-14 | $2.92M 10-Q · filed 2012-06-14 | $4.36M derived: sum of 3 quarters · filed 2012-06-14 | $5.68M derived: sum of 4 quarters · filed 2012-06-14 | ||||
| 2011-01-31 | $1.54M 10-Q · filed 2012-03-16 | $2.98M derived: sum of 2 quarters · filed 2012-03-16 | $4.31M derived: sum of 3 quarters · filed 2012-03-16 | |||||
| 2010-10-31 | $1.44M derived: 10-K 12 month − 10-Q/A 9 month · filed 2012-01-30 | $2.77M derived: sum of 2 quarters · filed 2012-01-30 | $5.98M 10-K · filed 2012-01-30 | |||||
| 2010-07-31 | $1.33M 10-Q/A · filed 2011-10-14 | $4.54M 10-Q/A · filed 2011-10-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 |